The Colorado “Impact of Ancestry and gender in omics of lung diseases (AGOLD)” is one of the newest members of the NIH/NHLBI “Programs to Increase Diversity among individuals Engaged in Health-Related Research (PRIDE).  We provide excellent faculty and resources at the highly-ranked Pulmonary and Critical care and Bioinformatics and Personalized Medicine divisions at the University of Colorado Anschutz Medical Campus. 

The objectives of AGOLD are to use precision medicine and omics technologies to unlock complex interactions between genes and pulmonary diseases and address existing disparities in application and interpretation of omics data to populations with African or native ancestry and the impact of gender to diseases such as interstitial lung disease, pulmonary hypertension or pulmonary fibrosis.